Portable diagnostic device for the detection of analytes in biological samples. The biosensor allows a label-free quantitative detection. Simple use, no qualified personnel needed.
Low-cost method with high effectiveness for the diagnosis and prognosis of thyroid cancers that are difficult to resolve during preoperative evaluation. It provides a malignancy score measuring the methylation level of various CpG sites determined by a machine learning classification system.
A signal amplification method for the simultaneous detection of respiratory RNA viruses in complex samples. The combination of molecular beacon technology and enzymatic digestion has proved to be a highly specific, cost-effective and fast alternative for detecting viral pathogens.
Novel polysaccharides that are effective in treatment and prevention of viral infections. These compounds are mimics of heparan sulfates present in cells. They act as decoy trap preventing the virus from adhering to epithelial cells, thus slowing down the process of infection.
A conjugate of fatty acids and amino acids has been found to protect neurons and facilitate the removal of protein aggregates that cause the most common neurodegenerative diseases. This opens the possibility of new, more effective and cheap treatments.
New carbon nanocapsules filled with enriched lithium compounds that can be applied in NCT for cancer treatment
Live attenuated vaccine incorporating a variant of the Rift Valley Fever virus obtained in the laboratory by serial passages in the presence of a mutagenic agent, that could be the basis of a new vaccine strain with safety parameters not previously described.
System based on an algorithm that allows for highly accurate diagnosis of breast cancer through the analysis of stochastic intracellular fluctuations of tumor cells, using images obtained through digital microscopy.
Two different vaccines prototypes have been developed based on RNA replicons from SARS-CoV-2 and MERS-CoV, encapsulated in Virus-Like Particles (VLPs), which can be used as a vaccines to generate immunity and protect against infections by these coronavirus.
A panel of high affinity nanobodies (Nb) binding to diverse SARS-CoV-2 RBD epitopes of spike protein, and a set of nanobody-derived neutralizing heavy chain antibodies (hcAbs) have been identified. They have potential as therapy against SRAS-CoV-2 for immunocompromised or non-responding to vaccines individuals.